“…We identified 33 eligible studies (total N = 517; age range 2-25 years, M = 15.53, SD = 6.44; 82.2% male), composed of eight double-blind RCTs [37-40, 43, 44, 46, 48], four double-blind, crossover RCTs [35,43,45,47], one doubleblind, sham-controlled trial [67], two single-blind RCTs [41,63], one single-blind controlled clinical trial [65], four openlabel studies [36,38,44,62], and 14 case series/studies [42, 51-61, 64, 66] (see Table 1 and 2). Seven studies were in ASD [35][36][37][38][39][40][41][42][43], seven in ADHD [44][45][46][47][48][49][50], four in schizophrenia [51][52][53][54], two in OCD [55,56], Tourette's syndrome [57,58], depression [59,60], anxiety [61,62], or substance abuse disorder [63,64], and one each in eating disorders…”